Clinical Indication

Type 2 Diabetes


If prescriber has not received specific training.
To be used in line with NICE Guidelines CG66
Once a week preparation (Bydureon®) is formulary.
Twice daily preparation (Byetta®) is non-formulary. However, existing patients may remain on treatment.

Date of classification

December 2010


Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.